200 related articles for article (PubMed ID: 19388937)
1. Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
Delgado J; Pratt G; Phillips N; Briones J; Fegan C; Nomdedeu J; Pepper C; Aventin A; Ayats R; Brunet S; Martino R; Valcarcel D; Milligan D; Sierra J
Br J Haematol; 2009 Jun; 145(6):801-5. PubMed ID: 19388937
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
Ma W; Kantarjian H; O'Brien S; Jilani I; Zhang X; Estrov Z; Ferrajoli A; Keating M; Giles F; Albitar M
Cancer; 2008 Mar; 112(6):1306-12. PubMed ID: 18224667
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
[TBL] [Abstract][Full Text] [Related]
5. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract][Full Text] [Related]
6. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia.
Rodriguez J; Cortes J; Talpaz M; O'Brien S; Smith TL; Rios MB; Kantarjian H
Clin Cancer Res; 2000 Jan; 6(1):147-52. PubMed ID: 10656443
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy results.
Delgado J; Espinet B; Oliveira AC; Abrisqueta P; de la Serna J; Collado R; Loscertales J; Lopez M; Hernandez-Rivas JA; Ferra C; Ramirez A; Roncero JM; Lopez C; Aventin A; Puiggros A; Abella E; Carbonell F; Costa D; Carrio A; Gonzalez M; ;
Br J Haematol; 2012 Apr; 157(1):67-74. PubMed ID: 22224845
[TBL] [Abstract][Full Text] [Related]
8. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria.
Tramonti G; Cipollini I; Annichiarico C; Lorusso P; Panicucci E; Mariani G; Barsotti G
J Nephrol; 2012; 25(6):976-82. PubMed ID: 22307441
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
[TBL] [Abstract][Full Text] [Related]
10. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
12. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
13. CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.
Hock BD; McKenzie JL; McArthur L; Tansley S; Taylor KG; Fernyhough LJ
Intern Med J; 2010 Dec; 40(12):842-9. PubMed ID: 20002855
[TBL] [Abstract][Full Text] [Related]
14. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of serum beta2-microglobulin in multiple myeloma].
Bettini R; Redaelli S; Maino C; Bertuol S; Costantini C; Lazzarini A; Brivio L; Gorini M
Recenti Prog Med; 2005 Feb; 96(2):81-6. PubMed ID: 15844767
[TBL] [Abstract][Full Text] [Related]
18. Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemia.
Yegin ZA; Ozkurt ZN; Yağci M
Eur J Haematol; 2010 May; 84(5):406-11. PubMed ID: 20059535
[TBL] [Abstract][Full Text] [Related]
19. Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.
Kawai K; Kawashima S; Miyazaki T; Tajiri E; Mori M; Kitazaki K; Shirotani T; Inatome T; Yamabe H; Hirata K; Yokoyama M
J Cardiol; 2010 Jan; 55(1):99-107. PubMed ID: 20122555
[TBL] [Abstract][Full Text] [Related]
20. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
